Your browser doesn't support javascript.
loading
Is there a ceiling lamotrigine serum level in epileptic children in remission?
Charfi, Rim; Gaies, Emna; Ben Sassi, Mouna; El Jebari, Hanene; Kammoun, Rania; Dahmene, Israa; Jebabli, Nadia; Salouage, Issam; Daghfous, Riadh; Trabelsi, Sameh.
Affiliation
  • Charfi R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia. Electronic address: charfirim@yahoo.fr.
  • Gaies E; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Ben Sassi M; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • El Jebari H; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Kammoun R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Dahmene I; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Jebabli N; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Salouage I; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Daghfous R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Trabelsi S; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
Therapie ; 77(4): 461-466, 2022.
Article in En | MEDLINE | ID: mdl-34973822
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy, Generalized / Epilepsy Type of study: Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Child / Humans Language: En Journal: Therapie Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy, Generalized / Epilepsy Type of study: Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Child / Humans Language: En Journal: Therapie Year: 2022 Document type: Article